|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 03-02 | SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion | MT |
| 11-07 | SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan | MT |
| Manager | Title | Age | Since |
|---|---|---|---|
Pia Renaudin
CEO | Chief Executive Officer | 59 | 2023-09-30 |
Michael Colérus
DFI | Director of Finance/CFO | 64 | 2013-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Diana Ferro
BRD | Director/Board Member | 60 | 2017-05-15 |
Jesper Høiland
CHM | Chairman | 66 | 2024-06-12 |
| Director/Board Member | 68 | 2024-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.67% | -3.02% | +19.09% | +46.26% | 257B | ||
| -1.61% | -1.02% | +5.06% | +12.29% | 164B | ||
| +2.03% | +3.33% | -16.11% | +62.19% | 151B | ||
| +2.45% | +4.02% | -55.79% | -8.41% | 64.51B | ||
| +0.12% | +2.23% | -15.36% | -11.09% | 52.1B | ||
| +0.02% | +3.18% | +11.40% | +65.53% | 51.9B | ||
| +1.92% | +1.98% | +16.92% | +30.11% | 50.95B | ||
| -2.12% | -0.89% | +19.27% | +59.12% | 50.11B | ||
| -0.32% | +2.34% | +30.37% | +77.80% | 44.95B | ||
| Average | -0.08% | +3.63% | +1.65% | +37.09% | 98.53B | |
| Weighted average by Cap. | -0.59% | +3.50% | +3.02% | +37.86% |
Employees
-
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















